[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346180-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346180-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-rna-binding-protein-elavl4hud-promotes-stress-associated-tumor-survival-in-neuroendocrine-cancers-review","The RNA-Binding Protein ELAVL4/HuD Promotes Stress-Associated Tumor Survival in Neuroendocrine Cancers - review","","Neuro-endocrine-related cancers overexpress ELAVL4 (HuD), a neuron-specific RNA-binding protein implicated in post-transcriptional regulation. HuD supports tumor cell survival: its knockdown in cancer cells and tumors reduces growth and viability. This review summarizes HuD’s roles across molecular pathways that foster cancer development, including stabilization of specific mRNAs that enhance adaptation to stressful tumor microenvironments, modulation of oxidative and metabolic stress, promotion of autophagy, and impairment of apoptosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-rna-binding-protein-elavl4hud-promotes-stress-associated-tumor-survival-in-neuroendocrine-cancers-review/346180/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-rna-binding-protein-elavl4hud-promotes-stress-associated-tumor-survival-in-neuroendocrine-cancers-review/346180.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is ELAVL4/HuD and what role does it play in neuroendocrine-related cancers?","Question",{"text":63,"@type":64},"ELAVL4 (HuD) is a neuron-specific RNA-binding protein overexpressed in neuro-endocrine-related cancers. It promotes tumor cell survival by supporting post-transcriptional regulation and key stress-response pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does HuD help tumor cells withstand stressful tumor microenvironments?",{"text":68,"@type":64},"HuD stabilizes certain mRNAs, enabling cells to better endure stressful microenvironments. This contributes to tumor development by influencing oxidative and metabolic stress responses and related survival programs.",{"name":70,"@type":61,"acceptedAnswer":71},"What is highlighted regarding future research and therapy development targeting HuD?",{"text":72,"@type":64},"The review discusses future studies focusing on HuD’s diverse roles across cancer types and molecular aspects. It also addresses how HuD may affect immunotherapy efficacy and how RNA-based or small-molecule targeted therapies could advance precision cancer management.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346180,1790722451,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Review  \nThe RNA-Binding Protein ELAVL4/HuD Promotes  \nStress-Associated Tumor Survival in Neuroendocrine Cancers  \nKausik Bishayee *, Vaishak Kaviyarasan, Sun Young Yoo, Seung Hee Lee and Yong Soo Park   \nAcademic Editor: Julia Kzhyshkowska  \nReceived: 27 July 2026  \nRevised: 28 August 2026  \nAccepted: 1 September 2026  \nPublished: 3 September 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nDepartment of Anatomy, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea;  \n[vikash.vaishak777@gmail.com](vikash.vaishak777@gmail.com) (V.K.); [easy11@catholic.ac.kr](easy11@catholic.ac.kr) (S.Y.Y.); [seunghui6310@hanmail.net](seunghui6310@hanmail.net) (S.H.L.);  \n[yongsoopark88@catholic.ac.kr](yongsoopark88@catholic.ac.kr) (Y.S.P.)  \n* Correspondence: [kausikbishayee1@gmail.com](kausikbishayee1@gmail.com)  \nAbstract  \nNeuro-endocrine-related cancers overexpress ELAVL4 (HuD), a neuron-specific RBP implicated in post-transcriptional regulation. HuD plays a role in tumor cell survival; its knockdown in cancer cells and tumors leads to reduced growth and viability. In this review, we addressed HuD’s role in several molecular pathways that contribute to the development of cancer. For example, cancer cells that have high levels of HuD are able to better withstand stressful tumor microenvironments because HuD stabilizes certain mRNAs, which promotes tumor development, modulates oxidative and metabolic stress, enhances autophagy, and impairs apoptosis. We discussed future studies on HuD in cancer, which should focus on its diverse roles in various cancer types and the molecular aspects.  \nFurthermore, assessing HuD’s contribution to the efficacy of immunotherapy requires an understanding of how it affects immune responses in malignancies. The development of targeted therapies, such as RNA-based approaches and small molecules, offers intriguing avenues for precision cancer management. The transition of HuD-directed therapies from preclinical models to clinical trials is anticipated tobe accelerated by ongoing advancementsin RNA-targeted drug discovery, structural biology, medicinal chemistry, and targeted drug delivery, even though no HuD-specific therapies have yet entered standard clinical practice.  \nKeywords: ELAVL4/HuD; GRB-10; ARL6IP1; mTORC1; cancer cell survival  \n1. Introduction  \nMammalian gene expression involves a complex and tightly controlled process that includes transcription, mRNA processing, transport, stability, and translation [1] . This regulation is influenced by RNA-binding proteins (RBPs) and unconventional RBPs. RBPs interact with specific mRNA sequences and can bind to single-or double-stranded RNA, playing a key role in various RNA functions that ultimately affect cell fate [2] . They protect target RNAs in the nucleus, ensuring effective nuclear export and completion of translation in the cytoplasm [3] . Over thousands of unique RBPs in humans and mice play functions in processes such as mRNA maturation, stabilization of protein complexes, alternative splicing, polyadenylation, and mRNA degradation [4] . Dysfunction of RBPs is linked to several diseases, including cardiovascular issues, immune disorders, cancer, and neurodegenerative diseases, particularly affecting conditions of the central nervous system like Alzheimer’s and Parkinson’s diseases [5] .  \nThe ELAV (embryonic lethal abnormal vision)/Hu family includes unique RBPs required for neurogenesis and post-transcriptional regulation. They stabilize mRNA and  \nregulate splicing and translation, particularly in brain tissues. Mammalian members (ELAVL1 (HuR), ELAVL2 (HuB), ELAVL3 (HuC), and ELAVL4 (HuD)) play an important role in neural growth and development as well as in neurological diseases and various cancers [5] . These proteins influence stability, transport, an","cbCaibs7fKblVbjc","https://ap.wps.com/l/cbCaibs7fKblVbjc","pdf",23487010,22,"English","# Introduction\n## ELAV/Hu family and neuroendocrine relevance\n## HuD mechanisms in RNA processing and stress responses\n# HuD in tumor survival pathways","[{\"question\":\"What is ELAVL4/HuD and what role does it play in neuroendocrine-related cancers?\",\"answer\":\"ELAVL4 (HuD) is a neuron-specific RNA-binding protein overexpressed in neuro-endocrine-related cancers. It promotes tumor cell survival by supporting post-transcriptional regulation and key stress-response pathways.\"},{\"question\":\"How does HuD help tumor cells withstand stressful tumor microenvironments?\",\"answer\":\"HuD stabilizes certain mRNAs, enabling cells to better endure stressful microenvironments. This contributes to tumor development by influencing oxidative and metabolic stress responses and related survival programs.\"},{\"question\":\"What is highlighted regarding future research and therapy development targeting HuD?\",\"answer\":\"The review discusses future studies focusing on HuD’s diverse roles across cancer types and molecular aspects. It also addresses how HuD may affect immunotherapy efficacy and how RNA-based or small-molecule targeted therapies could advance precision cancer management.\"}]","The RNA-Binding Protein ELAVL4/HuD Promotes Stress-Associated Tumor Survival in Neuroendocrine Cancers - review | PDF",1790060404,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00b838f22aa5911a99151112f954cb24.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a28103074812fcb295ef3256a56f2cb8.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f91de584a5ec52b5dc7b769f25f0b01d.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe2f04ee46037474e536e0f374cbf2ff.webp",980,1385]